Edwards Lifesciences Corporation (EW) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Edwards Lifesciences Corporation  (NYSE: EW)


Edwards Lifesciences's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Edwards Lifesciences's ROI in the third quarter of 2026?
Edwards Lifesciences Corporation achieved a return on average invested assets (ROI) of 8.26 % in its third quarter of 2026, which is below Edwards Lifesciences's average return on investment, which stands at 19.31%.

ROI fell compared to the second quarter of 2026, despite the net income growth of 27.38% from the second quarter of 2026.

Within the Healthcare sector 118 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 804 to 924.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 4.93 % 4.15 % 11.31 % 19.03 % 28.17 %
Y / Y Net Income Change TTM -25.08 % -75.77 % -71.29 % -69.04 % -55.61 %
Investment (TTM) in Millions 12,668 12,370 11,912 12,510 11,684
Return On Investment (TTM) 8.26 % 8.28 % 9.07 % 8.91 % 11.56 %
EW's Overall Ranking # 924 # 804 # 793 # 636 #
Seq. Investment Change TTM 2.03 % 0.47 % 0.46 % 1.9 % 1.27 %
Seq. Net Income Change TTM 1.71 % -8.24 % 2.27 % -21.51 % -67.1 %
Net Income (TTM) in Millions 1,021 1,004 1,094 1,069 1,363

EW Company Profile >> Back to EW Roi Comparisons >> See Annual EW Return On Investment



Return On Investment EW's Ranking
Within: No.
Industry # 39
Sector # 119
Overall # 924

Return On Investment Statistics
High Average Low
45.32 %
19.31 %
8.39 %
(Sep 30 2024)   (Jun 30 2026)







Financial Statements
Edwards Lifesciences's III. Quarter Investments $ 12,668 Millions EW's Balance sheet
Edwards Lifesciences's III. Quarter Income $ 308 Millions Quarterly EW's Income Statement
EW's Income by Division See EW's Income by Division


EW Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 11,884 11,615 8,237 7,270 7,470
Y / Y Investment Growth 2.32 % 41 % 13.3 % -2.68 % 17.77 %
Net Income in Millions 1,069 4,170 1,399 1,522 1,503
Y / Y Net Income Growth -74.35 % 197.96 % -8.05 % 1.25 % 82.55 %
Annual Return On Investment 9 % 35.9 % 16.99 % 20.93 % 20.12 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 9 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EW's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EW's Competitors
Subscribers only: Roi for Edwards Lifesciences's Suppliers
Subscribers only: Return On Investment for EW's Customers

Other Ratios
EW's Roa EW's Inventory Turnover Ratio EW's Growth Rates EW's Dividend Statistics
EW's Profitability Ratios EW's Asset Turnover Ratio EW's Dividend Growth
EW's Roe EW's Valuation Ratios EW's Financial Strength Ratios EW's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %
Bioventus Inc   11.26 %
Tenet Healthcare Corp  10.91 %

Date modified: 2026-11-06T12:55:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.